Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Limited human clinical trial data Most evidence is preclinical and observational
Umpierrez, V.T
Approval of the drug would be a win for Lilly as it tries to maintain dominance over the GLP-1 market, where it has already overtaken rival company Novo Nordisk, manufacturer of Ozempic and Wegovy
Despite advances in the understanding of disease pathogenesis, and the increased availability of treatment options, the prevalence of ESRD continues to rise in people living with T2DM [6]
Description For In Vitro Research Use Only Not for Human or Veterinary Application Specifications: Quantity: 10mg | 20mg | 30mg | 40 mg Form: Lyophilized Powder Intended Use: This compound is intended strictly for in vitro laboratory research by qualified professionals
US$ 26.96
US$ 21.82
US$ 21.38
